Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol - Wilson, Peter W.F.; Polonsky, Tamar S.; Miedema, Michael D.; Khera, Amit; Kosinski, Andrzej S.; Kuvin, Jeffrey T. (Journal of the American College of Cardiology, 2019)
Keywords: ACC/AHA Clinical Practice Guidelines; ACC/AHA Evidence Review Committee; biomarkers; Cardiovascular; cardiovascular disease; cholesterol; coronary artery calcium score; diabetes mellitus; drug therapy; ezetimibe; Guidelines; hydroxymethylglutaryl-CoA reductase inhibitors/statins; hypercholesterolemia; LDL-cholesterol; lipids; patient compliance; pharmacological; primary prevention; proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors; risk assessment; risk reduction discussion; risk treatment discussion; secondary prevention; ACC/AHA Clinical Practice Guidelines; cardiovascular disease; patient compliance; risk assessment; lipids; drug therapy; risk reduction discussion; secondary prevention; hydroxymethylglutaryl-CoA reductase inhibitors/statins; biomarkers; ACC/AHA Evidence Review Committee; proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors; diabetes mellitus; pharmacological; hypercholesterolemia; Guidelines; LDL-cholesterol; coronary artery calcium score; ezetimibe; primary prevention; cholesterol; risk treatment discussion